• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Surface Tethering of Inflammation-Modulatory Nanostimulators to Stem Cells for Ischemic Muscle Repair.用于缺血性肌肉修复的炎症调节纳米刺激器与干细胞的表面 tethering
ACS Nano. 2020 May 26;14(5):5298-5313. doi: 10.1021/acsnano.9b04926. Epub 2020 Apr 13.
2
Shear-Resistant, Biological Tethering of Nanostimulators for Enhanced Therapeutic Cell Paracrine Factor Secretion.用于增强治疗性细胞旁分泌因子分泌的抗剪切生物纳米刺激器的锚定。
ACS Appl Mater Interfaces. 2021 Apr 21;13(15):17276-17288. doi: 10.1021/acsami.1c01520. Epub 2021 Apr 8.
3
Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia.过表达乙醛酸酶-1逆转链脲佐菌素诱导的糖尿病小鼠模型中严重肢体缺血的糖尿病脂肪源性干细胞的促血管生成功能缺陷。
Stem Cells Transl Med. 2017 Jan;6(1):261-271. doi: 10.5966/sctm.2015-0380. Epub 2016 Aug 15.
4
Synergistic angiogenesis promoting effects of extracellular matrix scaffolds and adipose-derived stem cells during wound repair.细胞外基质支架和脂肪来源干细胞在创伤修复过程中的协同血管生成促进作用。
Tissue Eng Part A. 2011 Mar;17(5-6):725-39. doi: 10.1089/ten.TEA.2010.0331. Epub 2010 Dec 18.
5
Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice.心脏脂肪来源干细胞在C57BL/6小鼠中对心血管细胞表现出高分化潜能。
Stem Cells Transl Med. 2016 Feb;5(2):141-51. doi: 10.5966/sctm.2015-0083. Epub 2015 Dec 18.
6
Low-molecular weight heparin protamine complex augmented the potential of adipose-derived stromal cells to ameliorate limb ischemia.低分子量肝素鱼精蛋白复合物增强了脂肪来源的基质细胞改善肢体缺血的潜力。
Atherosclerosis. 2016 Jun;249:132-9. doi: 10.1016/j.atherosclerosis.2016.04.003. Epub 2016 Apr 6.
7
Exosomes derived from adipose-derived stem cells overexpressing glyoxalase-1 protect endothelial cells and enhance angiogenesis in type 2 diabetic mice with limb ischemia.过表达糖氧还蛋白-1 的脂肪来源干细胞衍生的外泌体保护内皮细胞并增强 2 型糖尿病小鼠肢体缺血模型中的血管生成。
Stem Cell Res Ther. 2021 Jul 15;12(1):403. doi: 10.1186/s13287-021-02475-7.
8
Substance P enhances proliferation and paracrine potential of adipose-derived stem cells in vitro.P物质在体外增强脂肪来源干细胞的增殖和旁分泌潜能。
Biochem Biophys Res Commun. 2017 Mar 25;485(1):131-137. doi: 10.1016/j.bbrc.2017.02.036. Epub 2017 Feb 10.
9
HIF1α overexpression enhances diabetic wound closure in high glucose and low oxygen conditions by promoting adipose-derived stem cell paracrine function and survival.HIF1α 过表达通过促进脂肪来源干细胞旁分泌功能和存活增强高糖和低氧条件下的糖尿病创面闭合。
Stem Cell Res Ther. 2020 Apr 5;11(1):148. doi: 10.1186/s13287-020-01654-2.
10
Adipose tissue-derived stem cells (ADSCs) transplantation promotes regeneration of expanded skin using a tissue expansion model.脂肪组织源性干细胞(ADSCs)移植利用组织扩张模型促进扩张皮肤的再生。
Wound Repair Regen. 2013 Sep-Oct;21(5):746-54. doi: 10.1111/wrr.12080. Epub 2013 Aug 12.

引用本文的文献

1
Injured renal cell membrane encapsulated ICG/CORM-401 for homologous targeted NIR theranostics of acute kidney injury.损伤的肾细胞膜包裹吲哚菁绿/一氧化碳释放分子-401用于急性肾损伤的同源靶向近红外诊疗。
J Nanobiotechnology. 2025 Aug 26;23(1):589. doi: 10.1186/s12951-025-03634-1.
2
Mechanistic insights into adipose-derived stem cells and exosomes in ischemia-reperfusion injury repair: from shared pathways to organ-specific therapeutics.脂肪来源干细胞和外泌体在缺血再灌注损伤修复中的机制洞察:从共同途径到器官特异性治疗
Front Cell Dev Biol. 2025 Jun 20;13:1621289. doi: 10.3389/fcell.2025.1621289. eCollection 2025.
3
Stem cell therapy: A promising therapeutic approach for skeletal muscle atrophy.干细胞疗法:一种治疗骨骼肌萎缩的有前景的治疗方法。
World J Stem Cells. 2025 Feb 26;17(2):98693. doi: 10.4252/wjsc.v17.i2.98693.
4
Enhancement of adipose stem cell quality via Cu-MON: Transcriptome and bioinformatics analysis of normal and diabetic stem cells.通过铜基金属有机网络增强脂肪干细胞质量:正常和糖尿病干细胞的转录组及生物信息学分析
FASEB Bioadv. 2025 Jan 18;7(3):e1485. doi: 10.1096/fba.2024-00153. eCollection 2025 Mar.
5
Synergistic effect of Hypoxic Conditioning and Cell-Tethering Colloidal Gels enhanced Productivity of MSC Paracrine Factors and Accelerated Vessel Regeneration.缺氧预处理与细胞锚定胶体凝胶的协同作用增强了间充质干细胞旁分泌因子的产生并加速了血管再生。
Adv Mater. 2025 Jan;37(3):e2408488. doi: 10.1002/adma.202408488. Epub 2024 Oct 9.
6
Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency.凋亡小体通过恢复 miR-145a-5p 的缺乏来挽救受损的间充质干细胞及其治疗骨质疏松症的能力。
J Nanobiotechnology. 2024 Sep 20;22(1):580. doi: 10.1186/s12951-024-02829-2.
7
Cu(II)-baicalein enhance paracrine effect and regenerative function of stem cells in patients with diabetes.铜(II)-黄芩素增强糖尿病患者干细胞的旁分泌作用和再生功能。
Bioact Mater. 2024 Jul 2;36:455-473. doi: 10.1016/j.bioactmat.2024.03.013. eCollection 2024 Jun.
8
Cell-drug conjugates.细胞药物偶联物。
Nat Biomed Eng. 2024 Nov;8(11):1347-1365. doi: 10.1038/s41551-024-01230-6. Epub 2024 Jul 1.
9
Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency.凋亡小泡通过恢复miR-145a-5p缺乏来挽救受损的间充质干细胞及其对骨质疏松症的治疗能力。
Res Sq. 2024 Jun 4:rs.3.rs-4416138. doi: 10.21203/rs.3.rs-4416138/v1.
10
Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications.脂肪来源的基质/干细胞培养技术的进展:对糖尿病及其并发症的影响。
Front Endocrinol (Lausanne). 2024 Apr 12;15:1343255. doi: 10.3389/fendo.2024.1343255. eCollection 2024.

本文引用的文献

1
IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide.IFNγ 和 TNFα 通过诱导一氧化氮协同诱导间充质干细胞/基质细胞凋亡。
Stem Cell Res Ther. 2019 Jan 11;10(1):18. doi: 10.1186/s13287-018-1102-z.
2
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery.通过 TCR 信号响应型纳米颗粒药物递送增强 T 细胞疗法。
Nat Biotechnol. 2018 Sep;36(8):707-716. doi: 10.1038/nbt.4181. Epub 2018 Jul 9.
3
Engineering the Surface of Therapeutic "Living" Cells.工程化治疗性“活”细胞的表面。
Chem Rev. 2018 Feb 28;118(4):1664-1690. doi: 10.1021/acs.chemrev.7b00157. Epub 2018 Jan 16.
4
Transplantation of Rat Mesenchymal Stem Cells Overexpressing Hypoxia-Inducible Factor 2 Improves Blood Perfusion and Arteriogenesis in a Rat Hindlimb Ischemia Model.过表达缺氧诱导因子2的大鼠间充质干细胞移植改善大鼠后肢缺血模型的血液灌注和动脉生成
Stem Cells Int. 2017;2017:3794817. doi: 10.1155/2017/3794817. Epub 2017 Nov 7.
5
Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells.缺氧诱导因子 1α 的过表达可改善牙髓间充质干细胞的免疫调节作用。
Stem Cell Res Ther. 2017 Sep 29;8(1):208. doi: 10.1186/s13287-017-0659-2.
6
Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events.简明综述:临床试验中脂肪源性细胞治疗的安全性评估:不良事件报告的系统综述。
Stem Cells Transl Med. 2017 Sep;6(9):1786-1794. doi: 10.1002/sctm.17-0031. Epub 2017 Jul 19.
7
Impacts of femoral artery and vein excision versus femoral artery excision on the hindlimb ischemic model in CD-1 mice.股动脉和静脉切除与股动脉切除对CD-1小鼠后肢缺血模型的影响。
Microvasc Res. 2017 Mar;110:48-55. doi: 10.1016/j.mvr.2016.12.006. Epub 2016 Dec 18.
8
Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy?再生医学中的间充质干/基质细胞:预处理策略能否提高治疗效果?
Transfus Med Hemother. 2016 Jul;43(4):256-267. doi: 10.1159/000447458. Epub 2016 Jul 20.
9
Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats.人骨髓间充质干细胞条件培养基对WKY大鼠抗GBM肾小球肾炎的治疗作用及机制
Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1182-91. doi: 10.1152/ajprenal.00165.2016. Epub 2016 Apr 6.
10
Phagocytosis: An Immunobiologic Process.吞噬作用:一种免疫生物学过程。
Immunity. 2016 Mar 15;44(3):463-475. doi: 10.1016/j.immuni.2016.02.026.

用于缺血性肌肉修复的炎症调节纳米刺激器与干细胞的表面 tethering

Surface Tethering of Inflammation-Modulatory Nanostimulators to Stem Cells for Ischemic Muscle Repair.

作者信息

Leong Jiayu, Hong Yu-Tong, Wu Yu-Fu, Ko Eunkyung, Dvoretskiy Svyatoslav, Teo Jye Yng, Kim Byoung Soo, Kim Kyeongsoo, Jeon Hojeong, Boppart Marni, Yang Yi Yan, Kong Hyunjoon

机构信息

Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.

Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, Singapore 138669, Singapore.

出版信息

ACS Nano. 2020 May 26;14(5):5298-5313. doi: 10.1021/acsnano.9b04926. Epub 2020 Apr 13.

DOI:10.1021/acsnano.9b04926
PMID:32243129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8274413/
Abstract

Stem cell transplantation has been a promising treatment for peripheral arterial diseases in the past decade. Stem cells act as living bioreactors of paracrine factors that orchestrate tissue regeneration. Prestimulated adipose-derived stem cells (ADSCs) have been proposed as potential candidates but have been met with challenges in activating their secretory activities for clinical use. Here, we propose that tethering the ADSC surface with nanoparticles releasing tumor necrosis factor α (TNFα), named nanostimulator, would stimulate cellular secretory activity . We examined this hypothesis by complexing octadecylamine-grafted hyaluronic acid onto a liposomal carrier of TNFα. Hyaluronic acid increased the liposomal stability and association to CD44 on ADSC surface. ADSCs tethered with these TNFα carriers exhibited up-regulated secretion of proangiogenic vascular endothelial growth factor and immunomodulatory prosteoglandin E2 (PGE) while decreasing secretion of antiangiogenic pigment epithelium-derived factors. Accordingly, ADSCs tethered with nanostimulators promoted vascularization in a 3D microvascular chip and enhanced recovery of perfusion, walking, and muscle mass in a murine ischemic hindlimb compared to untreated ADSCs. We propose that this surface tethering strategy for stimulation of stem cells would replace the costly and cumbersome preconditioning process and expedite clinical use of stem cells for improved treatments of various injuries and diseases.

摘要

在过去十年中,干细胞移植一直是治疗外周动脉疾病的一种有前景的方法。干细胞作为旁分泌因子的活体生物反应器,可协调组织再生。预刺激的脂肪来源干细胞(ADSCs)已被提出作为潜在候选者,但在激活其分泌活性以用于临床方面面临挑战。在此,我们提出用释放肿瘤坏死因子α(TNFα)的纳米颗粒(称为纳米刺激器)连接ADSC表面,将刺激细胞分泌活性。我们通过将十八烷基胺接枝的透明质酸与TNFα的脂质体载体复合来检验这一假设。透明质酸增加了脂质体稳定性以及与ADSC表面CD44的结合。与这些TNFα载体连接的ADSCs表现出促血管生成的血管内皮生长因子和免疫调节性前列腺素E2(PGE)的分泌上调,同时抗血管生成的色素上皮衍生因子的分泌减少。因此,与纳米刺激器连接的ADSCs在三维微血管芯片中促进了血管生成,并且与未处理的ADSCs相比,增强了小鼠缺血后肢的灌注恢复、行走能力和肌肉质量。我们提出这种用于刺激干细胞的表面连接策略将取代昂贵且繁琐的预处理过程,并加速干细胞在临床上的应用,以改善对各种损伤和疾病的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/415b2e267fe2/nihms-1717609-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/cac6fccebedb/nihms-1717609-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/e9b4707fa780/nihms-1717609-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/8f1fde28ae83/nihms-1717609-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/fc0d1cf23b5c/nihms-1717609-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/64677734c7d4/nihms-1717609-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/4f92152d6234/nihms-1717609-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/ef8724e5a5f5/nihms-1717609-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/9ea953be4f66/nihms-1717609-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/43ee5f5bbcd8/nihms-1717609-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/908ff3017ba2/nihms-1717609-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/415b2e267fe2/nihms-1717609-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/cac6fccebedb/nihms-1717609-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/e9b4707fa780/nihms-1717609-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/8f1fde28ae83/nihms-1717609-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/fc0d1cf23b5c/nihms-1717609-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/64677734c7d4/nihms-1717609-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/4f92152d6234/nihms-1717609-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/ef8724e5a5f5/nihms-1717609-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/9ea953be4f66/nihms-1717609-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/43ee5f5bbcd8/nihms-1717609-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/908ff3017ba2/nihms-1717609-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/8274413/415b2e267fe2/nihms-1717609-f0012.jpg